RxDoctor Payments Data

John Andreshak, MD

Orthopaedic Surgery of the Spine · Soldotna, AKNPI 1740270792

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $19,460 of the $22,119 with a category attached, or 88.0%. Kahtnu Surgical, Inc. accounts for 95.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $10,355 and has fallen 99.7% since, to $27 in 2025.

$22,119in general payments, 2019–2025

Across 26 payments — averaging $850.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kahtnu Surgical, Inc.$21K
  • Medtronic$449
  • Stryker$346
  • Globus Medical$89
  • Abbott$36

What the payments were for

  • Consulting fees$19,46088%
  • Travel & lodging$1,6948%
  • Food & beverage$9654%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Kahtnu Surgical, Inc.10$21,200
Medtronic(2 entities)10$449
Stryker3$346
Globus Medical1$89
Abbott2$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic surgery of the spine providers in Alaskato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$66,909
Medicare patients
120
Services billed
230

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin14$224

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Soldotna

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →